Form D · Other Health Care
HTG MOLECULAR DIAGNOSTICS, INC
Tucson, AZ · CIK 0001169987
Offering snapshot reported Mar 25, 2022 · SEC filing
- Reported sold
- $7.5M Offering amount: $20.9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2022 | Initial | $7,499,999 | No comparison | 1 | SEC filing |
| Oct 1, 2019 | Initial | $3,463,480 | No comparison | 2 | SEC filing |
| Jan 23, 2015 | Initial | $0 | No comparison | 19 | SEC filing |
| Sep 3, 2014 | Initial | $0 | No comparison | 2 | SEC filing |
| Feb 13, 2014 | Initial | $7,476,879 | No comparison | 15 | SEC filing |
| Nov 14, 2012 | Initial | $7,555,498 | No comparison | 9 | SEC filing |
| Jun 17, 2011 | Amendment | $14,399,998 | $4,389,999vs Mar 1, 2011 | 30 | SEC filing |
| Mar 1, 2011 | Initial | $10,009,999 | No comparison | 28 | SEC filing |
| Aug 6, 2010 | Initial | $1,738,500 | No comparison | 22 | SEC filing |
| Jul 23, 2009 | Amendment | $4,310,000 | No comparison | 7 | SEC filing |
| Nov 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 28, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 25, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $293K
- Finders' fees
- $0
- Form D file number
- 021-439028
Includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase common stock (assuming no cashless exercise).
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cantor Fitzgerald & Co. | 134 |
Source: Form D, filed Mar 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Bisgaard | Director |
| Kirk A. Collamer | Executive |
| Simeon George | Director |
| Harry A. George | Director |
| Michelle R. Griffin | Director |
| Donald W. Grimm | Director |
| Ann F. Hanham | Director |
| Don M. Hardison | Director |
| John M. Holliman | Director |
| Molly Hoult | Director |
| Timothy B. Johnson | Director |
| Christopher Kiritsy | Director |
| James T. La France | Director |
| John Lubniewski | Director, Executive |
| Lee R. Mc Cracken | Director |
| Shaun Mc Means | Executive |
| Bruce E. Seligmann | Director |
| Larry Senour | Director |
| Lewis Shuster | Director |
| Jim Weersing | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3430 E. Global Loop
Tucson, AZ, 85706
Tucson, AZ, 85706